• Fibrocor and Galapagos sign expanded collaboration in fibrosis

    Wednesday January 15th 2020

  • Imec ontwikkelt proces voor volumeproductie van microchip voor synthetisch DNA

    Monday January 13th 2020

  • Celyad Successfully Doses First Patient with CYAD-02 in CYCLE-1 Trial for r/r AML and MDS

    Monday January 13th 2020

  • Galapagos completes recruitment of PINTA trial in idiopathic pulmonary fibrosis

    Monday January 13th 2020

  • VIB Scientists develop ‘Twitter’ for cells

    Friday January 10th 2020

  • GHO Capital acquires Ardena, a leading CDMO providing early stage drug development and manufacturing for small-to-mid sized biopharma

    Thursday January 9th 2020

  • Antelope Dx receives grant from VLAIO to progress its home testing diagnostic device

    Wednesday January 8th 2020

  • Promethera® Announces Initiation of Phase 2b DHELIVER Study of HepaStem™ in Patients with Acute-on-Chronic Liver Failure (ACLF)

    Wednesday January 8th 2020

  • Your news here?

  • Mithra Signs License and Supply Agreement for Commercialization of Tibelia® in Italy

    Tuesday January 7th 2020

  • Oxurion NV Reports Positive Topline Data from Phase 1 study evaluating THR-687 for treatment of DME

    Tuesday January 7th 2020

  • Mithra Signs LSA with Alvogen for Commercialization of Estelle® in Hong Kong and Taiwan

    Monday January 6th 2020

Strategic Partners